Immunomodulatory activity of argentatins A and B isolated from guayule

Argentatins are secondary metabolites synthesized by guayule with numerous potential medical applications. In addition to inhibiting insect growth, they are endowed with several pharmacological properties including antimicrobial and antitumorigenic activity. However, their potential as immunomodulat...

ver descrição completa

Detalhes bibliográficos
Autores: Silva-Nolasco, Aniela M., Cruz-Morcillo, Miguel A. de la, García-Martínez, M. Mercedes, Zalacain, Amaya, González Gálvez, Beatriz, Carmona, Manuel
Formato: artículo
Fecha de publicación:2024
País:España
Recursos:Universidad Complutense de Madrid (UCM)
Repositorio:Docta Complutense
Idioma:inglés
OAI Identifier:oai:docta.ucm.es:20.500.14352/104737
Acesso em linha:https://hdl.handle.net/20.500.14352/104737
Access Level:acceso abierto
Palavra-chave:577.1
577.2
Biología molecular (Farmacia)
Bioquímica (Farmacia)
32 Ciencias Médicas
Descrição
Resumo:Argentatins are secondary metabolites synthesized by guayule with numerous potential medical applications. In addition to inhibiting insect growth, they are endowed with several pharmacological properties including antimicrobial and antitumorigenic activity. However, their potential as immunomodulators remains unexplored. The aim of the present study was to investigate whether argentatins can modulate the function of the immune system. Human mesenchymal stem cells were treated with argentatins and the production of several anti- and proinflammatory cytokines was evaluated. The effect of argentatins on the polarization of CD4+ T-lymphocytes and macrophages was also assessed. Results demonstrated that argentatins can modulate the production of proinflammatory cytokines and the polarization of cellular phenotypes, including Th2 lymphocytes and M1 macrophages. These findings suggest that argentatins are promising therapeutic agents in autoimmune or allergic diseases, and open new perspectives for the investigation of argentatins in immune response and in the development of more targeted and effective immunomodulatory therapies.